Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

University of Toronto

$120,000.00

Investigating Sex Differences in Neurodegenerative Disease Co-Pathologies to Enhance Diagnosis and Prognosis

FY 2025-26

Summary
Neurodegenerative diseases are conditions in which nerve cells in the brain slowly deteriorate and die, leading to progressive cognitive and behavioral decline. These conditions are marked by distinct disease related features such as toxic accumulation of proteins detrimental to brain function and subsequently human health. These abnormal proteins often live in combination and so make it difficult to provide an accurate diagnosis and treatment. Neurodegenerative diseases are becoming increasingly prevalent with the aging of the global population and lack effective therapy options placing a profound burden on affected individuals. Despite ongoing research, reliable tools to perform accurate diagnosis and prognosis remain limited posing a major clinical challenge. Our research aims to use blood, cerebrospinal fluid, skin and genetic assessments to look for markers that may accurately identify the cause of someone's impairments. We will also look at how being male or female affects these markers, helping us understand why the disease may look or progress differently in males and females. This study will help us understand how combinations of toxic proteins affect cognition and behavior, can predict how the disease will progress, and identify new targets for treatment. Ultimately, it will allow doctors to provide more personalized and effective care for each patient.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
559653
Name
Qamar Syeda H
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Investigating Sex Differences in Neurodegenerative Disease Co-Pathologies to Enhance Diagnosis and Prognosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Biofluid Analysis; Biomarker Discovery; Co-Pathologies; Diagnostic & Prognostic Biomarkers; Frontotemporal Lobar Degeneration (Ftld); Neurodegenerative Disease Pathophysiology; Rt-Quic & Single-Molecule Assays; Sex Differences / Sex As Biological Variable; Tauopathies; Translational Neuroscience
Abstract
Neurodegenerative diseases are conditions in which nerve cells in the brain slowly deteriorate and die, leading to progressive cognitive and behavioral decline. These conditions are marked by distinct disease related features such as toxic accumulation of proteins detrimental to brain function and subsequently human health. These abnormal proteins often live in combination and so make it difficult to provide an accurate diagnosis and treatment. Neurodegenerative diseases are becoming increasingly prevalent with the aging of the global population and lack effective therapy options placing a profound burden on affected individuals. Despite ongoing research, reliable tools to perform accurate diagnosis and prognosis remain limited posing a major clinical challenge. Our research aims to use blood, cerebrospinal fluid, skin and genetic assessments to look for markers that may accurately identify the cause of someone's impairments. We will also look at how being male or female affects these markers, helping us understand why the disease may look or progress differently in males and females. This study will help us understand how combinations of toxic proteins affect cognition and behavior, can predict how the disease will progress, and identify new targets for treatment. Ultimately, it will allow doctors to provide more personalized and effective care for each patient.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Qamar, Syeda H
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~